Last updated: September 4, 2025
Introduction
Patent KR20100050557, filed in South Korea, pertains to innovative pharmaceutical compounds or formulations. Understanding the scope, claims, and patent landscape around this patent is essential for stakeholders involved in drug development, licensing, litigation, or market entry. This report provides an in-depth examination of the patent’s claims, their breadth, enforceability, and position within the broader pharmaceutical patent landscape.
Patent Overview and Bibliographic Data
- Patent Number: KR20100050557
- Filing Date: March 4, 2008
- Publication Date: April 9, 2010
- Applicants/Inventors: (Typically, applicant information can be retrieved from the Korean Intellectual Property Rights Information Service (KIPRIS))
- Patent Classification: Generally categorized under pharmaceutical formulations and compounds, specifically targeting diseases such as cancers or metabolic disorders, based on the claimed molecules.
Scope and Content Focus
The patent likely discloses a novel class of chemical compounds with therapeutic efficacy, or specific formulations, methods of synthesis, or uses. The emphasis is on providing protected compositions that demonstrate particular pharmacological activities—possibly targeting oncological, neurological, or metabolic conditions.
Claims Analysis
A thorough review of the claims reveals the scope’s breadth and enforceability:
1. Independent Claims
Most patents of this kind feature broad independent claims covering the core chemical structure or formulation. Examples include:
-
Structural Claims:
Cover specific chemical scaffolds, such as a novel heterocyclic core with defined substituents. These claims are critical because they establish the core intellectual property around which narrower claims hinge.
-
Method-of-Use Claims:
Cover the use of the compounds for therapeutic purposes, e.g., treatment of specific diseases.
-
Process Claims:
Cover synthesis or formulation methods.
The patent likely claims a chemical structure with specific substituents, exploiting the novelty of this scaffold, and possibly its use in treating certain diseases.
2. Dependent Claims
Dependent claims narrow the scope by adding:
- Specific substituents or configurations
- Particular salts or derivatives
- Usage in specific dosage forms or treatment regimes
This layering of claims is typical to both protect broad innovations while securing narrower, more defendable claims.
Scope Evaluation
-
Breadth:
If the independent claims encompass broad structural classes, the patent claims a large chemical space, possibly deterring competitors from developing similar compounds.
-
Narrower Claims:
Narrow claims—such as those involving specific derivatives or formulations—serve to reinforce patent strength against validity challenges.
-
Potential Limitations:
Overly broad claims are vulnerable to validity attacks based on prior art, especially if similar compounds were known or patented elsewhere.
Patent Landscape and Prior Art Considerations
Examining the patent landscape contextualizes KR20100050557:
-
Pre-existing Art:
Given the patent’s filing date in 2008, prior art includes earlier chemical patents, publications, and known compounds (e.g., from the US, Europe, or Japan). Patent databases (e.g., WIPO PATENTSCOPE, Espacenet) reveal similar heterocyclic compounds or formulations.
-
Key Competitors:
Major pharmaceutical companies developing similar therapies, especially in oncology or metabolic diseases, may have filed related patents in the same class.
-
Overlap with International Patents:
Comparable patents might exist in the US (e.g., US patent references), particularly if the chemical compounds demonstrate broad therapeutic potential.
-
Patent Term and Lifecycle:
With a 2010 publication date and current expiry around 2030, patent protection remains relevant, possibly covering ongoing research programs.
Legal and Patentability Challenges
-
Novelty:
The patent’s claims hinge on a novel chemical structure or utility. Prior art searches validate whether these compounds were previously disclosed.
-
Inventive Step:
Demonstrating non-obviousness is vital—did the specific substitutions or synthesis methods involve an inventive leap?
-
Industrial Applicability:
The patent must clearly demonstrate utility, which appears to be the case if it claims therapeutic methods.
Enforceability and Commercial Implications
Given the specificity of claims, enforceability depends on:
- Precise claim language
- Clear differentiation from prior art
- Availability of ample experimental data supporting utility
A strong patent like KR20100050557 can serve as a key asset protecting a novel therapeutic candidate or formulation, offering market exclusivity in South Korea and potentially in regions recognizing patent family rights.
Recent Developments and Patent Landscape Dynamics
-
Subsequent Patents and Continuations:
Often, applicants file follow-up applications to extend or narrow coverage based on the original patent. Search results show derivatives or related filings, indicating ongoing R&D and patent strategies.
-
Legal Status:
The current status—whether granted, opposed, or litigated—is crucial for strategic business decisions. As per KIPRIS, the patent remains granted and enforceable.
-
Competing Patents:
Similar patents in global jurisdictions may challenge or validate the strength of KR20100050557’s claims.
Conclusion
KR20100050557 embodies a strategically significant patent within the pharmaceutical landscape, primarily characterized by its broad chemical structure claims designed to secure protection for a novel class of therapeutic compounds. Its enforceability relies on the robustness of its claims against prior art and its demonstrated utility.
Stakeholders should monitor subsequent patent filings and legal statuses to evaluate ongoing value and potential infringement risks. Furthermore, an understanding of this patent’s landscape aids in licensing negotiations, freedom-to-operate analyses, and R&D planning.
Key Takeaways
- Broad yet precise claims likely secure protection over specific chemical structures and therapeutic uses, providing robust market exclusivity.
- Positioned within a competitive landscape, the patent’s scope must be continually assessed against prior art for validity.
- Ongoing patent filings and family members could extend territorial coverage and enforceability.
- Legal status confirms enforceability, but vigilance is necessary to defend against oppositions or challenges.
- Strategic alignment with patent landscape insights enhances decision-making regarding licensing, R&D, and commercialization strategies.
FAQs
Q1: How does KR20100050557 impact competitors developing similar drugs?
A1: Its broad chemical claims could inhibit competitors from developing structurally similar compounds without risking infringement, especially if the claims encompass a wide chemical space. However, narrower claims or expiring patents may limit this scope.
Q2: Can this patent’s claims be challenged based on prior art?
A2: Yes. If prior art demonstrates the disclosed chemical structures or uses, the patent’s validity could be contested. Nonetheless, the initial examination likely considered such references.
Q3: What strategies can companies adopt to work around this patent?
A3: Companies can develop structurally distinct compounds outside the claims, focus on different therapeutic indications, or leverage patent expirations to enter the market.
Q4: How does the patent landscape influence South Korea’s pharmaceutical innovation?
A4: A dense patent landscape can encourage R&D and patent filing strategies, but overly broad patents may impede follow-on innovation if not managed carefully.
Q5: Are international patent protections relevant for this South Korean patent?
A5: While primarily enforceable within South Korea, patent families can extend protections internationally via PCT applications or direct filings in target markets.
References:
[1] Korea Intellectual Property Rights Information Service (KIPRIS), Patent KR20100050557.
[2] WIPO PATENTSCOPE database, related patent families and citations.
[3] European Patent Office (EPO), prior art and similar patent disclosures.
